Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2023-03-10 00:00:00 ET · period of report 2023-03-08 · accession 0001209191-23-017889 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-10 | 2023-03-08 | IRWD | Shetzline Michael | CMO, SVP, Head-Res, Drug | A - Grant | $0.00 | +69.9K | 331.5K | +27% | $0 |
| D | 2023-03-10 | 2023-03-08 | IRWD | Shetzline Michael | CMO, SVP, Head-Res, Drug | A - Grant | $0.00 | +34.9K | 34.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-03-08 | A | A | 69,869 | $0.00 | 331,455 | D | — | — | |
| 2 | Derivative | Performance-based Restricted Stock Units | 2023-03-08 | A | A | 34,935 | $0.00 | 34,935 | D | — · — to 2026-02-28 | 34,935 Class A Common Stock | (F2) Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share. |